Telix Pharmaceuticals Financials

Values in thousands	2025-06-30	2024-12-31	2024-06-30	2023-12-31
Revenue	$593,111	$594,244	$188,963	$281,713
Gross Profit	288,342	385,797	123,881	223,975
EBITDA	8,905	76,800	40,291	22,994
EBIT	-1,762	78,795	36,631	20,902
Net Income	-3,482	38,239	11,680	19,531
Net Change In Cash	593,111	594,244	188,963	281,713
Free Cash Flow	16,836	-10,916	19,913	2,840
Cash	207,156	710,346	118,837	123,237
Basic Shares	337,202	345,188	350,750	323,727

Values in thousands	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue	$783,207	$502,547	$160,096	$7,596
Gross Profit	509,678	314,390	29,337	-29,765
EBITDA	98,233	22,966	-92,837	-70,073
EBIT	92,547	16,223	-98,216	-75,247
Net Income	49,919	5,211	-104,079	-80,510
Net Change In Cash	783,207	502,547	160,096	7,596
Free Cash Flow	8,997	13,090	-77,831	-60,667
Cash	710,346	123,237	116,329	22,037
Basic Shares	345,188	323,710	310,644	282,206